Nasrat Hakim | President and Chief Executive Officer |
Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals First Quarter of Fiscal Year 2024 Conference Call. At this time, all lines have been placed on a listen-only mode.
Before management begins speaking, the Company has the following statements. Elite would like to remind their listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties that are subject to changes at any time, including, but not limited to, statements about Elite's expectations regarding future operating results.
Forward-looking statements are made pursuant to the Safe Harbor provisions of the federal securities laws and represent management's current expectation.